Surgery Partners (SGRY) affiliate reports sales of 1,794 and 272 shares

Rhea-AI Filing Summary

Surgery Partners, Inc. filing reports proposed and recent sales of common stock by an affiliate under Form 144.

The notice lists proposed dispositions tied to equity vesting dated 02/28/2026 and reports shares sold by William T. Webb: 1,794 shares on 03/05/2026 and 272 shares on 03/06/2026.

Insights

Securities Compliance Counsel

Form 144 notifies planned and recent dispositions by an affiliate; amounts are modest.

The filing lists equity vesting dated 02/28/2026 and two reported sales: 1,794 shares on 03/05/2026 and 272 shares on 03/06/2026. These are routine disclosures required when affiliated holders intend to sell restricted or control securities.

Regulatory timing and reporting obligations govern these notices; subsequent Form 4 or broker reports will show execution details and proceeds. The filing itself does not state proceeds or whether sales were under a plan.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	2045	26732.77	129341779	03/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	02/28/2026	equity vesting	Surgery Partners, Inc.			2045	02/28/2026	equity compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
William T. Webb 6216 Bridlewood Lane Brentwood TN 37027	common	03/05/2026	1794	24861
William T. Webb 6216 Bridlewood Lane Brentwood TN 37027	common	03/06/2026	272	3790

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Surgery Partners' (SGRY) Form 144 disclose?

The Form 144 discloses proposed and recent sales of common stock by an affiliate. It shows equity vesting dated 02/28/2026 and sales of 1,794 and 272 shares on 03/05/2026 and 03/06/2026 respectively.

Who reported the sales on the Form 144 for SGRY?

The reported sales were filed by William T. Webb. The notice lists his address and shows he reported dispositions of 1,794 shares on 03/05/2026 and 272 shares on 03/06/2026, tied to equity vesting.

Are the amounts in the Form 144 large enough to be material?

The filing reports small share amounts: 1,794 and 272 shares. These figures are modest in isolation and the filing does not present any claim of material impact on capitalization or control.

Does the Form 144 state how much cash the company received?

No. The Form 144 lists proposed or reported dispositions of common stock but does not disclose cash proceeds or the buyer. Proceeds and execution details are not provided in the excerpt.

Is the Form 144 tied to equity compensation for SGRY?

Yes. The filing references an equity vesting date of 02/28/2026, indicating the securities relate to equity compensation that vested on that date, as stated in the notice.